The literature is scarce in the evaluation of Behçet's disease (BD) among individuals during
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Then, an …

Abstract Objective The implications of Covid-19 in patients with Behçet's disease (BD) are
unknown. Patients with BD usually take long-term therapy with therapeutic agents that have …

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is the cause of the global
pandemic that originated in China in December 2019 [1]. It had spread all over Turkey in …

Initial case series of small number of patients at the beginning of the pandemic reported a
rather guarded prognosis for Behçet's syndrome (BS) patients infected with SARS-CoV-2. In …

DISCUSSION: Our case highlights that B. cepacia may complicate COVID-19 even in
immunocompetent patients. To our knowledge, this is the first reported case of B. cepacia …

We read with interest the study of Monti et al, 1 the first rheumatic disease cases with COVID-
19. In detail, the authors described the clinical course of COVID-19 in a series of 11 patients …

Objectives To present the clinical characteristics, disease course, management, and
outcomes of COVID-19 infection in patients with Behcet's disease (BD). Methods In this …

Conventional debates surrounding the treatment of coronavirus disease 2019 still continue
in the literature. Colchicine is one of the recommended agents in the treatment of …

COVID‐19 is a multisystem disease caused by severe acute respiratory syndrome
coronavirus 2. It has been declared a pandemic by the World Health Organization in March …

Background: Burkholderia gladioli (B gladioli) is a rare, gram-negative rod that was initially
regarded as a plant pathogen. However, B gladioli has been reported as the primary …